Primary analysis of MURANO study data for R/R CLL
Updates from the highly anticipated Phase III MURANO study (NCT02005471) in relapsed/refractory chronic lymphocytic leukemia (CLL) were presented at the American Society of Hematology (ASH) 2017 Annua...
Author: VJHemOnc
Added: 12/13/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Study